Zacks Research Has Positive Outlook of MD FY2026 Earnings

Pediatrix Medical Group, Inc. (NYSE:MD) – Zacks Research upped their FY2026 earnings per share (EPS) estimates for shares of Pediatrix Medical Group in a research note issued on Monday, March 10th. Zacks Research analyst Z. Masood now expects that the company will post earnings per share of $1.44 for the year, up from their previous forecast of $1.43. The consensus estimate for Pediatrix Medical Group’s current full-year earnings is $1.38 per share.

Pediatrix Medical Group (NYSE:MD) last posted its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million during the quarter, compared to analysts’ expectations of $486.22 million.

MD has been the subject of several other reports. UBS Group raised their price objective on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a “neutral” rating in a research report on Friday, February 21st. Mizuho raised their price objective on shares of Pediatrix Medical Group from $13.00 to $15.00 and gave the stock a “neutral” rating in a research report on Tuesday, November 19th. Macquarie began coverage on shares of Pediatrix Medical Group in a research report on Monday, December 16th. They issued an “outperform” rating and a $18.00 price target for the company. StockNews.com upgraded shares of Pediatrix Medical Group from a “hold” rating to a “buy” rating in a research report on Wednesday, January 22nd. Finally, Truist Financial lifted their price target on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the company a “hold” rating in a research report on Friday, February 21st. Four equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus price target of $17.08.

Pediatrix Medical Group Trading Down 0.8 %

Pediatrix Medical Group stock opened at $13.93 on Thursday. Pediatrix Medical Group has a 52 week low of $6.62 and a 52 week high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The stock has a market capitalization of $1.20 billion, a P/E ratio of -11.60, a PEG ratio of 1.74 and a beta of 1.48. The stock has a 50-day simple moving average of $14.12 and a 200 day simple moving average of $13.37.

Institutional Trading of Pediatrix Medical Group

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Quest Partners LLC grew its stake in shares of Pediatrix Medical Group by 25.6% during the third quarter. Quest Partners LLC now owns 3,054 shares of the company’s stock worth $35,000 after buying an additional 622 shares during the last quarter. Everence Capital Management Inc. grew its stake in shares of Pediatrix Medical Group by 7.5% in the fourth quarter. Everence Capital Management Inc. now owns 13,840 shares of the company’s stock worth $182,000 after purchasing an additional 960 shares during the last quarter. Parkside Financial Bank & Trust grew its stake in shares of Pediatrix Medical Group by 36.1% in the fourth quarter. Parkside Financial Bank & Trust now owns 3,919 shares of the company’s stock worth $51,000 after purchasing an additional 1,040 shares during the last quarter. Nomura Asset Management Co. Ltd. grew its stake in shares of Pediatrix Medical Group by 95.3% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company’s stock worth $33,000 after purchasing an additional 1,220 shares during the last quarter. Finally, Quarry LP grew its stake in shares of Pediatrix Medical Group by 54.1% in the third quarter. Quarry LP now owns 4,735 shares of the company’s stock worth $55,000 after purchasing an additional 1,662 shares during the last quarter. Institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.